Healthcare Stocks – Best Healthcare Stocks In India 2024

The table below shows the best healthcare stocks in India in 2024 based on the highest market capitalization.

Best Healthcare Stocks in India

The Table below shows the best Healthcare stocks in India based on 1 Year Return.

Healthacare Stocks In India

The Table below shows the Healthcare stocks in India based on 1 Month Return.

Best Healthcare Stocks

The Table below shows the best Healthcare stocks in India based on PE Ratio.

Best Healthcare Stocks

The Table below shows the best Healthcare stocks in India based on Daily Volume.

Healthcare sector stocks

The Table below shows the best Healthcare stocks in India based on 52 Week High.

What Are Hospital Stocks?

Hospital stocks are shares of companies that own or operate hospitals and healthcare facilities. These stocks represent investments in the healthcare sector, focusing on the provision of medical services, patient care, and related operations. Investors are attracted to hospital stocks due to their essential nature and potential for stable returns.

Top Healthcare Stocks In India

The table below shows the Top Healthcare Stocks In India based on 1 Year Return. 

Best Healthcare Stocks In India

The table below shows the Best Healthcare Stocks In India based on the highest day Volume.

Healthcare Sector Stocks In India

The table below shows Healthcare Sector Stocks In India based on the PE Ratio. 

Healthcare Sector Stocks List

The table below shows the Healthcare Sector Stocks List based on the 6-month return. 

Who Should Invest In Top Healthcare Stocks In India?

Investors looking for stable and potentially high returns should consider investing in top healthcare stocks in India. These include long-term investors, those seeking diversification in their portfolios, and individuals who believe in the growth potential of India’s healthcare sector. Consulting with a stock broker can provide valuable insights and guidance.

How To Invest In The Top Healthcare Stocks In India?

To invest in the top healthcare stocks in India, research and identify leading companies in the sector. Open a trading account with a reliable stock broker, analyze the financial health and growth potential of selected stocks, and purchase shares through your broker’s platform. Monitor your investments regularly for optimal returns.

Performance Metrics Of Top Healthcare Stocks In India

One of the key performance metrics for top healthcare stocks in India is Earnings Per Share (EPS). EPS measures the profitability of a company by dividing its net profit by the number of outstanding shares, providing insight into how much profit each share generates.

1. Price-to-Earnings (P/E) Ratio: This metric evaluates a stock’s market value in relation to its earnings, helping investors gauge whether the stock is over or undervalued.

2. Return on Equity (ROE): ROE indicates how effectively a company uses shareholders’ equity to generate profits, reflecting management’s efficiency.

3. Debt-to-Equity Ratio: This ratio compares a company’s total debt to its shareholders’ equity, assessing the risk and financial leverage.

4. Dividend Yield: It measures the annual dividend income relative to the stock’s current price, indicating the income potential for investors.

5. Price-to-Book (P/B) Ratio: The P/B ratio compares a company’s market price to its book value, providing insights into how much investors are paying for each unit of net asset value.

Benefits Of Investing In Top Healthcare Stocks In India

The main benefits of investing in construction stocks in India can provide substantial returns and long-term stability due to the country’s growing healthcare needs and advancements in medical technology.

1. Growing Demand: The increasing population and rising awareness of health and wellness drive continuous demand for healthcare services and products.

2. Technological Advancements: Ongoing innovations and adoption of advanced medical technologies can lead to enhanced treatment methods and efficiency.

3. Government Support: Favorable policies and substantial investments by the Indian government in healthcare infrastructure boost the sector’s growth prospects.

4. Defensive Sector: Healthcare is considered a defensive sector, meaning it is less susceptible to economic downturns compared to other industries.

5. Diversification: Investing in healthcare stocks adds diversity to an investment portfolio, reducing risk by spreading investments across different sectors.

Challenges Of Investing In Best Hospital Stocks In India

The main challenges of Investing in the best hospital stocks in India can be regulatory hurdles and high operational costs, which may affect profitability and growth potential.

1. Regulatory Hurdles: The healthcare sector is heavily regulated, which can impact the operational flexibility and profitability of hospitals.

2. High Operational Costs: Running a hospital involves significant expenses, including medical equipment, staff salaries, and maintenance.

3. Market Competition: Intense competition among hospitals can limit market share and impact profitability.

4. Economic Sensitivity: Economic downturns can affect the affordability of healthcare services, reducing patient inflow and revenue.

5. Technological Advancements: The constant need for upgrading medical technology can lead to high capital expenditure.

6. Healthcare Policies: Changes in government healthcare policies and insurance regulations can directly affect hospital revenues and patient volumes.

Introduction To Best Healthcare Stocks In India 

Max Healthcare Institute Ltd

The Market Cap of Max Healthcare Institute Ltd is Rs. 88,745.32 crores. The stock’s monthly return is 19.35%. Its one-year return is 52.51%. The stock is 6.22% away from its 52-week high.

Max Healthcare Institute Limited is an India-based healthcare company. The Company operates through the Medical and Healthcare Services segment. The Company also operates a homecare business and pathology business under the brand names Max@Home and Max Lab. Max@Home offers health and wellness services at home. 

Max Lab provides pathology services outside its hospital network. The Company is specialized in providing treatment for cancer care/oncology, cardiac sciences, endocrinology and diabetes, eye care/ophthalmology, gastroenterology, hepatology and endoscopy, laparoscopic/minimal access surgery, neurosciences, liver transplant and biliary sciences, orthopedics and joint replacement, bariatric surgery/metabolic, robotic surgery, kidney transplant, bone marrow transplant, urology, and vascular surgery. 

Apollo Hospitals Enterprise Ltd

The Market Cap of Apollo Hospitals Enterprise Ltd is Rs. 87,674.13 crore. The stock’s monthly return is 1.72%. Its one-year return is 22.09%. The stock is 11.01% away from its 52-week high.

Apollo Hospitals Enterprise Limited is an India-based integrated healthcare company. The Company is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers, and pharmacies. 

The Company’s segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. It is engaged in hospitals and hospital-based services. The Retail Health and Diagnostics segment includes clinics and diagnostics. The Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods, and private label products business from various services using the digital platform.  

Fortis Healthcare Ltd

The Market Cap of Fortis Healthcare Ltd is Rs 34,690.33 crore. The stock’s monthly return is -3.55%. Its one-year return is 49.82%. The stock is 8.37% away from its 52-week high.

Fortis Healthcare Limited is an India-based integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company operates through the healthcare services segment. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. 

It manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics, and daycare specialty facilities. It has approximately 27 healthcare facilities, including projects under development, 4500 operational beds, and over 400 diagnostics centers. 

Global Health Ltd

The Market Cap of Global Health Ltd is Rs. 34,241.40 crores. The stock’s monthly return is 6.01%. Its one-year return is 92.54%. The stock is 19.02% away from its 52-week high.

Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. 

It provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson’s disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others.  

Narayana Hrudayalaya Ltd

The market cap of Narayana Hrudayalaya Ltd is Rs. 24,833.02 crore. The stock’s monthly return is 1.47%. Its one-year return is 24.54%. The stock is 18.05% away from its 52-week high.

Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. 

The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology – oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation, and infectious diseases.  

Dr. Lal PathLabs Ltd

The Market Cap of Dr. Lal PathLabs Ltd is Rs. 23,138.09 crore. The stock’s monthly return is 4.95%. Its one-year return is 25.39%. The stock is 2.41% away from its 52-week high.

Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. 

It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. 

Poly Medicure Ltd

The Market Cap of Poly Medicure Ltd is Rs. 18,874.70 crores. The stock’s monthly return is 7.51%. Its one-year return is 70.26%. The stock is 7.18% away from its 52-week high.

Poly Medicure Limited is an India-based medical devices company. The Company is primarily in the business of manufacture and sale of medical devices. The Company offers a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, COVID care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. 

It supplies its products to approximately 120 countries, in Europe, Africa, America, Australia, and Asia. Its products include a suction control valve, safety arterial cannula, VTM Kit, VLTM kit, blood collection needle with a flashback, and pre-filled syringes.  

Aster DM Healthcare Ltd

The market cap of Aster DM Healthcare Ltd is Rs. 17,412.10 crores. The stock’s monthly return is -3.64%. Its one-year return is 20.79%. The stock is 60.92% away from its 52-week high.

Aster DM Healthcare Limited is a healthcare service provider. The Company’s segments include Hospitals, Clinics, Retail Pharmacies and Others. The Hospitals segment comprises of hospitals and in-house pharmacies at the hospitals. The Clinics segment comprises of clinics and in-house pharmacies at the clinics. 

The Retail Pharmacies segment comprises standalone retail pharmacies and optical outlets. The Other segment comprises healthcare consultancy services. Its geographical segments consist of Gulf Corporation Council (GCC) States, including the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait, Bahrain, and India. The Company’s healthcare services are offered under Aster, Medcare, and Access brands.  

Krishna Institute of Medical Sciences Ltd

The Market Cap of Krishna Institute of Medical Sciences Ltd is Rs. 16,757.02 crores. The stock’s monthly return is 12.73%. Its one-year return is 20.42%. The stock is 11.04% away from its 52-week high.

Krishna Institute of Medical Sciences Ltd is an India-based company that is principally engaged in the business of rendering medical and healthcare services. The Company’s departments include accident, Alzheimer Center, andrology and infertility center, pediatric obesity, pediatric oncology, pediatric oncology, and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center, and hepatobiliary surgery center. 

Its technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, and Impella. The Company’s institutes include the Institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, and Institute of Neuro Sciences.

Rainbow Children’s Medicare Ltd

The Market Cap of Rainbow Children’s Medicare Ltd is Rs. 12,754.19 crores. The stock’s monthly return is -5.52%. Its one-year return is 35.63%. The stock is 27.25% away from its 52-week high.

Rainbow Children’s Medicare Limited is an India-based company engaged in the business of rendering medical and healthcare services. The Company is a multi-specialty pediatric, and obstetrics and gynecology hospital operating over 16 hospitals and three clinics in six cities, with a total bed capacity of approximately 1,655 beds. 

It offers pediatric services under Rainbow Children’s Hospital, which include newborn and pediatric intensive care, pediatric multi-specialty services, and pediatric quaternary care (including multi-organ transplants). Its women’s care services under Birthright by Rainbow offer perinatal care services which include normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care along with gynecology services.  

Top Healthcare Stocks In India – FAQs

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.

Here are some of the Best Stock Research Articles listed based on Top Sectors (Industries), Market Cap, and Fundamental Analysis Factors:

Click the link to access the web story now: Best Healthcare Stocks in India

Disclaimer: The above article is written for educational purposes. The securities quoted are exemplary and are not recommendatory.